EGFR and neoplasm: However, the results from this study pinpoint the dynamic and rapid shift of tumor phenotype and sensitivity to therapies and highlight the small window in which EGFR blockade can be most beneficial in the setting of combinations with immune-mediated anti-cancer approaches.